We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 20.27%
2 Healthcare 16.18%
3 Financials 13.98%
4 Consumer Discretionary 13.5%
5 Industrials 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRT icon
1376
STRATTEC Security
STRT
$338M
$4.91M ﹤0.01%
245,534
+573
+0.2% +$12.2K
SPR
1377
DELISTED
Spirit AeroSystems
SPR
$4.89M ﹤0.01%
59,495
-5,568,950
-99% -$436M
EXTN
1378
DELISTED
Exterran Corporation
EXTN
$4.87M ﹤0.01%
373,120
-91,456
-20% -$1.11M
SIBN icon
1379
SI-BONE Inc
SIBN
$852M
$4.87M ﹤0.01%
275,400
-26,393
-9% -$506K
INVH icon
1380
Invitation Homes
INVH
$17.7B
$4.85M ﹤0.01%
163,922
+11,300
+7% +$318K
GNTX icon
1381
Gentex
GNTX
$4.93B
$4.85M ﹤0.01%
175,996
+15,333
+10% +$405K
CRVS icon
1382
Corvus Pharmaceuticals
CRVS
$1.27B
$4.81M ﹤0.01%
1,596,569
-165,679
-9% -$695K
OHI icon
1383
Omega Healthcare
OHI
$13.9B
$4.8M ﹤0.01%
114,910
-82,529
-42% -$3.21M
MDSO
1384
DELISTED
Medidata Solutions, Inc.
MDSO
$4.77M ﹤0.01%
52,125
+208
+0.4% +$19K
ERIE icon
1385
Erie Indemnity
ERIE
$13.5B
$4.67M ﹤0.01%
25,173
-24,615
-49% -$5.59M
AGNC icon
1386
AGNC Investment
AGNC
$13B
$4.65M ﹤0.01%
289,118
+20,907
+8% +$343K
UGI icon
1387
UGI
UGI
$7.53B
$4.64M ﹤0.01%
92,305
-203
-0.2% -$10.1K
AKRO
1388
DELISTED
Akero Therapeutics
AKRO
$4.64M ﹤0.01%
203,913
+2,413
+1% +$56.1K
TCF
1389
DELISTED
TCF Financial Corporation Common Stock
TCF
$4.62M ﹤0.01%
121,367
+67,011
+123% +$2.67M
TPIC
1390
DELISTED
TPI Composites
TPIC
$4.58M ﹤0.01%
244,009
+8,556
+4% +$183K
ROKU icon
1391
Roku
ROKU
$22.9B
$4.52M ﹤0.01%
44,441
+17,139
+63% +$2.1M
LPX icon
1392
Louisiana-Pacific
LPX
$5.15B
$4.5M ﹤0.01%
183,285
-1,799
-1% -$44.3K
EPR icon
1393
EPR Properties
EPR
$4.7B
$4.5M ﹤0.01%
58,522
+14,950
+34% +$1.14M
BJ icon
1394
BJs Wholesale Club
BJ
$11.8B
$4.45M ﹤0.01%
171,843
-893,415
-84% -$22.2M
LEA icon
1395
Lear
LEA
$8.16B
$4.39M ﹤0.01%
37,216
+1,671
+5% +$203K
OLED icon
1396
Universal Display
OLED
$4.18B
$4.37M ﹤0.01%
26,037
+905
+4% +$181K
KOD icon
1397
Kodiak Sciences
KOD
$2.5B
$4.33M ﹤0.01%
+301,249
New +$3.93M
HHH icon
1398
Howard Hughes
HHH
$4.04B
$4.31M ﹤0.01%
34,853
+982
+3% +$121K
WRI
1399
DELISTED
Weingarten Realty Investors
WRI
$4.24M ﹤0.01%
145,551
+9,823
+7% +$271K
GMS
1400
DELISTED
GMS Inc
GMS
$4.23M ﹤0.01%
147,352
-5,790
-4% -$142K

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.